
Addition of bone marrow aspirate to TCP show no benefit in radiographic outcomes

Addition of bone marrow aspirate to TCP show no benefit in radiographic outcomes
Ultraporous B-Tricalcium Phosphate Alone or Combined with Bone Marrow Aspirate for Benign Cavitary Lesions: Comparison in a Prospective Randomized Clinical Trial
J Bone Joint Surg Am. 2013 Jan 16;95(2):158-66. doi: 10.2106/JBJS.K.00181Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
55 patients were randomized to evaluate the healing of cavity defects filled with ultraporous B-tricalcium phosphate (TCP) versus TCP and bone marrow aspirate (TCP/BM). Patients with a benign bone lesion received either TCP or TCP/BM and were assessed at 24 months. Results revealed that while significant improvements in radiographic parameters were reported in both groups, the addition of BM did n...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.